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Abstract
Background: Genome-scale “-omics” measurements are challenging to benchmark due to the enormous variety of
unique biological molecules involved. Mixtures of previously-characterized samples can be used to benchmark
repeatability and reproducibility using component proportions as truth for the measurement. We describe and
evaluate experiments characterizing the performance of RNA-sequencing (RNA-Seq) measurements, and discuss
cases where mixtures can serve as effective process controls.
Results: We apply a linear model to total RNA mixture samples in RNA-seq experiments. This model provides a
context for performance benchmarking. The parameters of the model fit to experimental results can be evaluated
to assess bias and variability of the measurement of a mixture. A linear model describes the behavior of mixture
expression measures and provides a context for performance benchmarking. Residuals from fitting the model to
experimental data can be used as a metric for evaluating the effect that an individual step in an experimental
process has on the linear response function and precision of the underlying measurement while identifying signals
affected by interference from other sources. Effective benchmarking requires well-defined mixtures, which for
RNA-Seq requires knowledge of the post-enrichment ‘target RNA’ content of the individual total RNA components.
We demonstrate and evaluate an experimental method suitable for use in genome-scale process control and lay
out a method utilizing spike-in controls to determine enriched RNA content of total RNA in samples.
Conclusions: Genome-scale process controls can be derived from mixtures. These controls relate prior knowledge
of individual components to a complex mixture, allowing assessment of measurement performance. The target
RNA fraction accounts for differential selection of RNA out of variable total RNA samples. Spike-in controls can be
utilized to measure this relationship between target RNA content and input total RNA. Our mixture analysis method
also enables estimation of the proportions of an unknown mixture, even when component-specific markers are not
previously known, whenever pure components are measured alongside the mixture.
Keywords: RNA sequencing, RNA-seq, Gene expression, Mixture deconvolution, Expression deconvolution, Process
control, Spike-in control, ERCC
Background
Measurement assurance for genome-scale measurements
is challenged by the impracticality of creating a sample
containing known quantities of tens of thousands of
components, such as the RNA transcripts measured in
an RNA-seq experiment. Deep sequencing of cellular
RNA can generate vast quantities of gene expression
information, yet measurement biases have been identified
at nearly every step of the library preparation process [1–4].
As RNA-sequencing expression data expands from
discovery into clinical applications, the sources and
magnitudes of bias and variability must be carefully
understood and quantified. The basic units of expression
in sequencing, such as transcripts per million reads
(TPM) or fragments per kilobase per million reads
(FPKM), are still undergoing revision [5, 6]. Even when
using comparable units, it is rarely possible to directly
compare gene expression values reported by different labs,
on different instruments, or frequently just on different
days [6–8], unless special care is taken to use uniform
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samples and protocols. Identifying the presence and
variation of biases in a measurement process over
time requires a standard to be used for process control.
The regular use of a process control can help determine
the most-appropriate protocol and analysis methods,
demonstrating that the measuement process accurately
represents the true changes in the underlying sample.
Ideally, a measurement process is linear and possesses
a known precision. A linear measurement process shows
an increase in signal proportional to an increase in the
object being measured. It is also helpful if measured sig-
nal is additive, arising only from a single source. Preci-
sion consists of repeatability and reproducibility, defined
as the degree of closeness in multiple measurements made
by a single user and the closeness between multiple labs,
respectively. We show that mixtures can demonstrate that
a measurement’s response function is linear and of high
specificity (free of interference or cross talk) while
measuring its variability and precision. Properly con-
structed mixture samples can be used to correct for
systematic measurement errors, provide ongoing mon-
itoring of performance, serve as a tool for interlabora-
tory comparison, and create a context for evaluating
batch effects, protocols, and informatic analyses.
There are two known approaches to creating useful
genome-scale standards. One is the creation of a limited
number of external spike-in controls, such as those
designed by the External RNA Controls Consortium
(ERCC), which were created for microarrays and have
been applied to next-gen sequencing [9–11]. A second
approach utilizes mixtures of previously characterized
samples in defined ratios, and has also been applied to
microarrays [12–14] but has not been utilized in other
genome-scale measurements. Using these types of stan-
dards provides confidence in the ability of a test to detect
both positive and negative results, determining the limits
of that detection.
Mixtures can serve as a test that applies to each of the
tens of thousands of transcripts in a sample’s transcrip-
tome. Linearity of the measurement response can be dem-
onstrated based on the fundamental understanding that a
mixture is a linear combination of its components. Previ-
ous work with mixtures in microarrays [12–14] utilized an
arbitrary 10-fold “selectivity” cutoff to evaluate the linear
dynamic range of microarray measurements and under-
stand the variability of these measurements. The arbitrary
selectivity cutoff in previous work prevents the identifica-
tion of interference, as any genes affected by interference
would be filtered by the stringent selectivity cutoff.
Using known mixture compositions, predicted values
can be calculated based on the assumption that the meas-
urement response is linear. Deviation of the observed
values from the model-predicted value is an indication of
bias in the measurement. Systematic biases could be
introduced by sample preparation, signal processing, inter-
ference from related or mis-annotated genes, or sampling
variation. Signal arising from off-target molecules, such as
a closely related transcript, can cause false positive results
and result in a lowered specificity. Mixture samples can
provide information about the measurement sensitivity,
specificity, repeatability, reproducibility, dynamic range,
and limit of detection.
Determining the relative contributions to gene expression
of individual components within mixtures of biological
states has received some attention in clinical research,
where biopsies and other patient samples are often
mixtures. The process of resolving gene expression
signals introduced by each individual component of a
mixture [13–23] has been used to account for tumor
heterogeneity and to separate whole blood samples
into individual cell types. These procedures often sep-
arate mixture components based on a subset of genes
forming a signature that varies uniquely between
components. These deconvolution methods have been
used [24–27] to develop high-resolution tumor ex-
pression signatures from imperfect biological samples
[28, 29] and differentiate between cell-type-frequency
changes and per-cell gene expression changes [17, 30].
Many of these methods can determine mixture compo-
nent types by using a linear model where mixture expres-
sion is treated as a combination of expression signatures.
None of these methods corrects for RNA enrichment.
Different cell types express different total amounts of
RNA of varying types, confounding estimates of cell type
proportion made based on the quantification of total RNA
[31]. Others have introduced the concept of a biological
scaling factor [32, 33] to compensate for variation in the
RNA content of cells, including the use of spike-in
controls to determine this factor. The enrichment of
subclasses of RNA from total RNA (as in polyA selection)
adds a bias to the experiment due to the different
abundance of RNA classes between cell types.
We assess linear response, specificity, and accuracy of
genome-scale measurements using mixtures. In the
process, we demonstrate that linear models can be used to
separate these mixtures into the proper components. We
were mindful that while our mixtures were of total RNA,
the sequencing process enriches for RNA subclasses, and
that differential enrichment is an important factor when
interpreting results. We anticipate that a mixture-based ap-
proach to measurement assurance is highly generalizable
to many types of mixtures and can be extended to the wide
variety of genome-scale measurements, including but not
limited to proteomic and metabolomic measurements.
Results
To assess measurement parameters of genome-scale tran-
scriptome data, we analyzed two RNA-seq experiments
Parsons et al. BMC Genomics  (2015) 16:708 Page 2 of 13
measuring synthetic mixtures of commercially available
human total RNA samples (Fig. 1) [13, 14, 34]. First, we
analyzed data generated as part of the Sequencing Quality
Control Consortium (SEQC) project [34, 35], which
contained two mixture samples as part of their inter
laboratory experiment. In this study, the 9 laboratories se-
quenced the following samples: Universal Human Refer-
ence RNA spiked with ERCC ExFold RNA Spike-in Mix 1
(SEQC-A), Human Brain Reference RNA spiked with
ERCC ExFold RNA Spike-in Mix 2 (SEQC-B) and two
mixtures of SEQC-A and SEQC-B (SEQC-C and SEQC-D)
with mixture compositions C = 3A + 1B and D = 1A + 3B.
In a second experiment, which we call BLM, we gener-
ated multiple libraries of two mixtures (BLM-1 and
BLM-2) composed of total RNA isolated from human
brain (B, the same RNA as SEQC-B), liver (L), and
muscle (M) tissue were measured for this study. These
two mixtures were made with component proportions of
1B:1L:2M and 1B:2L:1M. The total RNA of each individ-
ual tissue were also sequenced as single component
samples to provide an expression signature for each tis-
sue. ERCC spike-in control RNAs [12] prepared by NIST
were added to the BLM mixtures and individual compo-
nents. Two spike-in control pools were designed with
ratiometric differences in the concentration of individual
ERCC spike-ins. The multiple libraries of BLM-1 and
BLM-2 mixtures were spiked with either of these pools
at one of three (high, low, medium) concentrations. As
expected based on the mixture designs, ERCCs spiked-in
equally yielded similar expression signal, while signal from
ERCCs spiked differentially into multiple subpools was at
ratios corresponding to the designed fold changes. Poisson
sampling at the lower expression levels results in in-
creased dispersion about the expected ratio [36].
These mixtures were designed to have a defined
expression signal ratio between them. For example, if
the measurement response were linear and unbiased, the
signal in the SEQC-C sample would be exactly 1/4 the
signal of SEQC-B plus 3/4 the signal from SEQC-A due
to the design of the mixture. However, these total RNA
mixtures went through RNA-seq library preparation by
polyA selection, which purposely removes certain classes
of RNA, such as ribosomal RNA, from the sample. As
the resulting sequence data comes from only the se-
lected subset, the fraction of which can be different
from sample to sample, a correction for this differen-
tial enrichment must be applied to accurately reflect
the experimental process and allow the model to re-
turn the designed ratios of expression between mix-
tures (Additional file 1: Figure S1).
Linear model-based analysis of genome-scale gene
expression
We observed that mixture expression is a linear combin-
ation of the component samples and the mixture pro-
portions of each component. Equation 1 describes the
relationship between signal in the mixtures and signal in
the constituent samples. A mixture M (two per dataset in
this study) is composed of a number of named compo-
nents C (“B”,”L”, and”M” in the Brain/Liver/Muscle mix-
ture or “A” and “B” in the SEQC dataset), with each
component comprising a proportion of the mixture. ΦC.
i,M is the expression signal arising from a particular
gene/transcript i in mixture M.
i;M¼i;C ΦC;M ð1Þ
This study uses four mixtures of the same general
form:
i;BLM1¼i;B ΦB;1þi;L ΦL;1þi;M ΦM;1
i;BLM2¼i;B ΦB;2þi;L ΦL;2þi;M ΦM;2
i;SEQC−C¼i;SEQC−A ΦA;Cþi;SEQC−B ΦB;C
i;SEQC−D¼i;SEQC−A ΦA;Dþi;SEQC−B ΦB;D
These mixtures were made of total RNA, while the
expression signal (sequencing reads) arises only from
the enriched RNA. As the fraction of the total RNA mass
that matches the enrichment criteria varies between cell
Fig. 1 RNA samples used in this study. RNA isolated from pure tissues is used to generate pairs of mixtures used in two separate experiments.
a Two SEQC mixtures (SEQC-C and SEQC-D) are built from two components (SEQC-A and SEQC-B). b Two BLM mixtures (BLM-1 and BLM-2) are
built from three components. The SEQC-B component (HBRR) is from the same source as the Brain BLM component. Per-sample target ratios of
tissue proportion between mixtures are shown
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types, the enrichment of total RNA introduces a bias.
Additional file 1: Figure S1 shows the offset from the
expected ratios of tissue-specific and ERCC RNA caused
by this bias. We correct the specific equations for the
enrichment fraction by multiplying each component by a
factor ρ. This factor corresponds to the fraction of mea-
sured RNA compared to the mass of total RNA in each
mixture. ρC is defined as the fraction of measured RNA
per unit total RNA in component C.
Including this factor, the BLM1 mixture equation
becomes Eq. 2:
i;BLM1¼i;B ΦB;1  ρBþi;L ΦL;1  ρLþi;M ΦM;1  ρM
ð2Þ
There are a few approaches that have been described to
measure ρ. One study directly measured the post-
selection RNA content between SEQC-A and SEQC-B
samples [37]. Another described the use of trimmed mean
of log expression ratios (TMM) [32] to measure a bio-
logical scaling factor based on enriched RNA directly from
RNA-seq data. These TMM-derived factors have been
shown to be an appropriate measure in cases where there
is no global expression level change (such as the SEQC
mixtures), but are not applicable if there are global expres-
sion changes (such as in the BLM mixtures) [33].
The ρ factor can be determined using spiked-in RNA
[33] as sample reads per microgram of total RNA di-
vided by spike-in reads per microgram of spike-in RNA.
This factor utilizes the differential enrichment between
polyadenylated spike-in RNA and total RNA, which is
only partly composed of polyadenylated RNA.
Figure 2 compares the distributions of spike-in esti-
mated rho factor ratios across the SEQC samples com-
pared to the direct measurement of poly-A enriched RNA
made previously [37]. While the ρ factors do not directly
measure the polyA content of a sample due to relatively
inefficient but consistent polyA capture of the spike-in
RNA, ratiometric measurements of pairs of samples have
distributions that are similar to that of a normal dis-
tribution with parameters based on the previous en-
richment measurements of SEQC-A and SEQC-B.
Additionally, the expected equalities of ρC = ρA*.75+
ρB*.25 and ρD = ρA*.25+ ρB*.75 hold true to within
5 % of ρA, indicating that the enriched RNA content of a
mixture is a linear combination of the enriched RNA con-
tent of its components. Additionally, solving the system of
BLM equations only for the enrichment fractions (input-
ting the known proportion values) yields very similar
enrichment fractions to those calculated from spiked-in
RNA, leading us to be confident in these measurements.
The target RNA fraction ρ is a property of an individual
RNA sample and can be affected by any sample manipula-
tion - chief among them the polyA selection step in
sample preparation. For replicates within a single polyA-
selected SEQC experimental run, the ρ of a mix varies
slightly, likely due to fluctuations in efficiency of polyA
selection. (Additional file 2: Table S1) It is also important
to note that FPKM units should not be used to calculate
the enrichment fraction (Additional file 3: Figure S2), as
the FPKM derivation [6] includes a term coupling sample
abundance to spike abundance.
Mixture analysis models recapitulate known mixture
proportions
To demonstrate the accuracy of this analytical frame-
work of mixtures, the mixture proportions ΦBLM were
recalculated for the BLM mixtures BLM-1 and BLM-2.
The ρ values and the sequencing expression data Xi were
used to solve for the mixture proportions ΦBLM by linear
regression to the mixture equation. Figure 3 shows that
the experimentally observed counts are highly correlated
(R^2 = 0.996) to the equation-solved counts Xi for each
transcript. Figure 4 shows the ΦBLM values at which re-
siduals were minimized for the two mixtures for each
replicate sample in each laboratory. Estimates of the
three component proportions in the two mixtures are
consistent with the designed 25:25:50 and 25:50:25 pro-
portions in the two BLM mixtures. Figure 5 shows that
the designed proportions of SEQC mixtures across each
of nine labs can also be calculated by this equation,
returning the 75:25 and 25:75 proportions for mixes C
and D, with some variability between labs. Eq. 1, which
lacks correction for enrichment fraction, does not return
the designed ratios (Additional file 4: Figure S3).
Linear model-predicted mixture counts are equivalent to
replicate measures
In studies by the SEQC [34], differential expression
between replicate samples was utilized to evaluate
measurement performance based on the hypothesis
that the control samples used in the study had no
true differences between replicates. We created
pseudo-replicate predicted count values from the single
component samples for use in benchmarking. These sim-
ulated mixtures were built based on the measured mixture
expression and the true mixture proportions.
Figure 6 shows a dendrogram of the distance between
actual mixture expression and predicted expression
counts of SEQC samples. The four base samples A, B, C,
and D are most distant from one another, reflecting the
biological differences between the samples. Samples A
and C are more closely related, as C consists of 75 % A
and 25 % B. Modeled pseudo-replicate samples Cm and
Dm across each of the six SEQC sites are no more
different than cross-lab replicates of the C and D data,
indicating that building the model for mixture C from
components A and B does not introduce significant
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Fig. 2 Distributions of empirical (light) and ERCC-estimated (dark) enrichment ratios between SEQC samples A:B, A:C, and A:D. The empirical
distribution was simulated from a normal distribution with means of 2.87 and 2.003 and standard deviations of 0.095 and 0.124 for samples
A and B, as reported previously [37]. The ERCC-estimated values were calculated from Equation 3. Individual labs’ RNA enrichment varied inside
a narrow range, yielding discrete peaks in the distribution for some outlying labs
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variability. This supports the treatment of modeled mix-
tures as replicate measurements expected to have no
true differential expression from the mixture samples.
Any detected differential expression between a mixture
and its predicted expression values is indicative of a bias
in the measurement process. In the BLM or SEQC data-
sets, differential expression was detected only in the
ribosomal RNA genes (NR_003286.2, NR_003287.2,
NR_023363.1). This detected differential expression re-
flects the sample to sample variance in rRNA depletion.
Fig. 3 Comparison of observed and predicted counts. Observed BLM mix 1 counts (x) are plotted against predicted BLM mix 1 counts (y). Predicted
counts are calculated using eq. 2. Counts are on the log2 scale
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Discussion
Mixtures of biological samples can be useful as process
controls for measurements with linear response functions.
A mixture can be treated as linear combination of its
components. Two experimental datasets with known mix-
ture parameters were used to test the linearity of RNA-seq
measurements. In RNA-seq, the enrichment of the total
RNA mixture components by polyA selection must be
accounted for, as the sequencing experiment measures
only the RNA which passes this enrichment filter.
Mixtures with either known or unknown proportions
can be analyzed. If mixture proportion information is
known a priori, genome-scale data can be used as a
process control to test the repeatability and sensitivity of
measurements by comparing observed and expected
measures. Alternatively, if the mixture proportions are
an unknown and desired parameter, expression measures
from the mixture in combination with the single compo-
nents can be used to experimentally determine the
mixture proportions. This application can be valuable in
un-mixing biological mixtures, including clinical mixtures,
cell cultures, and xenografts [24–29]. While target RNA
fraction correction is required for RNA-sequencing
measurements, the general mixture model is theoretically
applicable to any measurement with a linear response
function.
Mixtures can provide measurement process assurance
to a sequencing experiment. Using mixture samples
alongside pure samples, one can demonstrate the repro-
ducibility and sensitivity of genome-scale RNA, protein, as
well as metabolite measurements. The main goal of this
type of mixture analysis is to create a known ratio value
by which the measurement characteristics of an experi-
ment can be assessed. While an experiment’s measure-
ment of this known ratio is not sufficient to prove the
validity of the measurement, it is a necessary condition,
and any deviations are indicative of bias.
We demonstrate process control usage of mixtures by
comparing the nine SEQC sites. Figure 5 shows a sum-
mary plot of the estimated component fractions for each
sample. The dispersion and bias of the points from the
target value give an indication of the overall process
Fig. 4 Accuracy of model-derived BLM mix estimates. The grey center point is the nominal ‘truth’ ratio in which the samples were mixed. Concentric
circles with radius at multiples of 0.025 are added to visually clarify distance from the center point. Colored points depict mixture proportion (Φ)
estimates generated from measurements of 4 replicate libraries. Black points are the mean of the replicates. Error bars show one standard deviation
of the four replicate measures
Parsons et al. BMC Genomics  (2015) 16:708 Page 7 of 13
accuracy. Within this set of labs there are easily discern-
ible changes, which could indicate process errors. Site 1
looks strong – there is no bias, and a modest and regular
level of dispersion. In site 2 the dispersion of component
C is exaggerated, suggestive of an issue in the handling
of that particular sample. Site 4 has less dispersion than
site 1, but has introduced a bias. Site 7 is from a com-
pletely different sequencing instrument, and shows that
there is similar dispersion to the previous instrument,
with a bit of a bias. However, site 8 shows that this bias
does not occur in every run. This comparison of SEQC
sites shows that even these summary plots can detect dif-
ferences between runs. It is for this reason that we suggest
the use of mixtures as process controls for RNA-seq
experiments. Comparing the dispersion and bias of your
measurement against the known truth of mixtures as you
make changes to your experimental process allows you to
evaluate the effect of these changes on the measurement
quality. Table 1 describes several types of changes that can
be evaluated in this way.
While we demonstrate mixture analysis with two spe-
cific samples, the analysis is generalizable to any number
or type of mixture components. Any mixture split into
known individual components can be measured in this
way. For example, a clinical researcher may have three
samples of interest from healthy, chronically diseased
and acutely diseased sources. A mixture of these three
cell types would provide confidence in the measure-
ments made on the three samples individually by
verifying the repeatability of that measurement. It can
also provide a benchmark sample to assess compar-
ability over space and time. These mixtures can de-
tect biases introduced by batch effects, operator
effects, sample mislabeling, and technical artifacts
Fig. 5 Mixture proportion (Φ) estimates for samples A in SEQC-C and SEQC-D. The mean (black hollow circle) and standard deviation (error bars)
of four individual replicates (colored) of the Φ estimate for each sample are shown. The nominal mixture proportions are grey points at the center
of the target. Circles centered at that nominal ratio with radii in multiples of .025 are included to more easily identify magnitude of total error.
LT and ILM tags indicate the manufacturer of the sequencer used at each lab (Life Technologies and Illumina, respectively). Deviations from the
target indicate process variability, instrument bias, or errors brought about in these labs
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while evaluating the variability of the measurement.
Mixture samples with known proportions can help
determine experimental reproducibility and discover
technical artifacts introduced by the measurement
process by comparison of the expected to observed
proportions.
With this analytical model, end users and core facil-
ities can use known mixtures as a process control to
track changes in measurement quality whenever
changes to the experimental process are made. By in-
cluding a predefined mixture, cross-sample compari-
sons can be made to demonstrate the internal
consistency of measurements made using any new ex-
perimental technique, kit, or downstream analysis
tool. In this way, there is some assurance that
changes in experimental protocol have not affected
measurement reproducibility. Residuals from modeled
counts can be used as a metric to evaluate the mag-
nitude of effect an experimental process has on the
linearity and precision of underlying measurements.
In addition to gaining an understanding of the measure-
ment process using the benchmarking workflow, unknown
samples can be collected and studied to determine the rela-
tive proportion of known components. Proportions of
components can be determined even in the absence of any
type-specific markers, given measurable differences in
expression between the cell types.
Resolving the composition of mixtures has proven
useful in determining the purity of cell lines or propor-
tions of heterogeneous cells, in identifying interesting
cellular contaminants such as partially differentiated
cells, and understanding clinical samples containing
mixed cell types. In contrast to approaches using trans-
gene expression [38], the mixture model described here
can evaluate tissue sample purity without focusing on a
handful of tissue-specific genes, marker genes, or trans-
genes. We expect mixed-sample RNA to be useful in
regulatory applications, where a demonstration that a
therapeutic stem-cell mixture has a specific compos-
ition may be key to ensuring safety and efficacy [39].
Fig. 6 Clustering of Expression measures in 4 SEQC samples and 2 in-silico replicate samples across participating sites: The close agreement between
modeled (Cm, Dm) counts and actual counts (A, B, C, D) at sites numbered 1–6 supports the validity of assumptions used to model Cm and Dm
counts. Euclidian distance measures between samples show that the various samples are of greater distance from one another, while the in-silico
modeled samples are most similar to the correct corresponding sample
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Spike-in controls measure post-enrichment RNA content
of samples
In addition to providing limit of detection and cross-
experiment comparison characterizations of a dataset,
spike-in controls can be used in mixture samples to de-
termine the enriched RNA fraction of cells. Enrichment
fraction is a critical parameter for comparing samples
that do not have identical total RNA content. This is
most relevant to cells with variable global expression
[31], including comparisons across and within cell cycle,
tissues, and developmental states [40]. Enrichment frac-
tion is also critical in single cell gene expression studies,
where lysis efficiency and total RNA content can vary
greatly from cell to cell.
We demonstrate that the ERCC controls can be used
as an estimator of enriched RNA content within sam-
ples. Of note, the SEQC study [34] results showed a
large degree of variation in sample sequencing library
preparation even at the same site, but that the sequen-
cing library replicates prepared at a single site and then
sequenced at multiple laboratories resulted in very con-
sistent measurements between sites. Variation in library
prep is primarily due to variability in RNA enrichment,
and is the primary source of variability in spike-in con-
trols [41, 36].
There are many methods used to determine compo-
nent gene expression profiles from mixture samples. To
the best of our knowledge, our method is the only one
that accounts for RNA enrichment as calculated via
spike-in controls. When comparing samples of variable
RNA content, bias arises when that variability is not
accounted for. We describe a straightforward method
for measuring the enrichment of target RNA in RNA-
seq samples using spike-in RNA. We show that
enrichment-corrected deconvolution of two mixture
datasets returns the best approximation of known mix-
ture proportions (Figs. 4 and 5), demonstrating suitabil-
ity for solving unknown mixtures of known components.
Previous methods used to determine the composition of
RNA-seq mixtures make inaccurate estimates of mixture
proportion in the BLM sample where the enrichment
fractions vary substantially between mixture components.
These methods are nearer to true values in the SEQC
sample, where the RNA content difference between
samples is less significant, but all estimates are im-
proved by incorporating enrichment fraction measure-
ment (Additional file 4: Figure S3).
Recommendations for use
Control mixtures most easily demonstrate that an experi-
mental process is linear and internally consistent, and can
track the changes in variability over time. A first experi-
ment with a new process should utilize these controls to
demonstrate the reproducibility of measurements between
single component and mixture samples. Subsequently,
changes to the process can be evaluated by comparing the
model residuals before and after the change. For example,
a lab interested in changing from a total RNA measure-
ment to a messenger RNA measurement may wish to
evaluate if this change had any effect on sequencing out-
put. The change in the sum of residuals between these
two different experiments would allow a global compari-
son, while the change in residuals of individual genes may
highlight a set of genes, which become inconsistently
biased between experiments. Table 1 shows three potential
use cases for mixtures used as process control.
Limitations
Although mean mixture proportion values returned from
a linear combination of mixture components approximate
the nominal mixture proportion in both measured sam-
ples, the increased variability of the muscle estimate in the
BLM mixture (error bars, Fig. 4) suggests that there is a
lower limit to being able to determine low-abundance
mixture components. Due to a lower target RNA fraction
in muscle, that component of the BLM mix was as low as
10 % of sequenced RNA in BLM-2. It may be possible to
determine lower-proportion mixture components with
confidence, but this study did not generate the required
data to do so.
Our estimation of targeted RNA fraction is imperfect; an
assumption of the model we built is that the enrichment
Table 1 Example use cases for process control mixtures




Mix 2–3 components of biological interest





Demonstrate the ability of a protocol and/or
technology platform to consistently measure
transcripts of interest
Core Labs Repeated measures of highly-available
samples
After changes in technician,
prototol, reagents, or
technology platform, etc.




Informaticians Relevant samples, public data
(eg: SEQC, this study)
When comparing informatics
analysis tools or developing
new tools
Use non-simulated benchmark datasets to
determine how accurate results are.
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proportion is constant between replicates of the same
sample. Additional file 2: Table S1 shows that the
actual enrichment varies by as much as 5 % from li-
brary to library. This variability is a source of error in
our model. The variability in enrichment is likely due
to batch effects in the polyA selection process. This
hypothesis is reinforced by the prevalence of non-
polyA transcripts incorrectly called as differentially
expressed between mixture replicates. Another limita-
tion is that the targeted RNA fraction is based on
total RNA mass, rather than per cell. Researchers in-
terested in the relative proportions of cells in a mix-
ture will additionally need a measurement of average
mass per cell. The sequencing technology and library
preparation methods used in these experiments also
added limitations to the experiments. These are de-
scribed in Additional file 5: Note S1.
Conclusions
We demonstrate the linear response function and speci-
ficity of RNA-sequencing measurements using mixtures
of biological samples. We recommend the use of such
mixtures as benchmarks to characterize the repeatability
and reproducibility of experiments. Spike-in controls
can be used to calculate the measured RNA content of
total RNA mixtures, compensating for biases introduced
by polyA enrichment or similar RNA enrichment tech-
niques. Our method creates a framework for using
mixtures in measurement process control and corrects
for biases introduced by RNA selection. Correction for
differential enrichment improves the accuracy of mixture
proportion determination in RNA-seq experiments.
Benchmarking genome-scale measurements using
mixed samples will remain useful even after the era of
short-read sequencing is over. Answering the biological
question of “what types of cells are in the mixture I’m
sequencing?” requires more information than even a
perfect transcriptome reconstruction could provide. The
biological and measurement value added by mixed sam-
ples are demonstrated here to be platform-independent.
We anticipate that mixtures can provide the same meas-
urement assurance to protein and metabolite measure-
ments. Confidence in the reproducibility of measurement
and understanding the components in complex biological
samples will always be a staple of quality science.
Methods
Library preparation
For the BLM experiment, Human Brain Reference RNA,
Human Liver Total RNA, and Human Skeletal Muscle
Total RNA were purchased from Ambion. Human RNA
tissues were purchased from Ambion. Ambion certifies
that all human derived materials have been prepared
from tissue obtained with consent from a fully informed
donor or a member of the donor’s family.
This purified RNA was quantified by absorbance on a
NanoDrop 1000, mixed in the specified proportions,
then spiked with ERCC RNA transcribed from NIST
SRM 2374. For Illumina sequencing, the Illumina
TruSeq protocol was followed. HiSeq runs generated
100 + 100 bp paired-end reads. Solid 5500 sequencing
followed the Life Technologies Whole Transcriptome
protocol, yielding 75 + 35 bp paired-end reads. Spike-
in composition and amounts are included in the data
submission to ENA.
Quantitation and data normalization
BLM gene counts were based on raw count data quanti-
fied using HTSeqCounts [40] based on a variety of gen-
ome and transcriptome references [42–45] after mapping
reads to the genome with Tophat [46]. Raw counts were
then normalized using the upper quartile method imple-
mented in EdgeR [36]. Additional file 4: Figure S3 utilizes
RSEM [47]. HTSeq-counts version 0.5.4 was run with op-
tions to deal with non-stranded reads in the intersection-
nonempty mode. The SEQC data used are available as
count tables from GEO GSE47774. Counts used in the
final data analysis are from the UCSC “all genes” reference
modified to add ERCC controls.
Calculating unknown mixture estimates
The relative abundance of components in unknown mix-
tures were calculated by first observing the mean target
RNA fraction for the neat components across replicates.
The count data in the mixture was set as the response,
predicted by the count data from the individual compo-
nents modified by the enrichment fraction, as based on
the mixture equations. An example R script ‘generalmix-
turesolver’ is provided at http://github.com/usnistgov/
mixtureprocesscontrol as a supplemental file to clarify
this procedure.
Availability of data and materials
The SEQC data is available from GEO GSE47774. [http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47774].
The BLM data is available from the European Nucleo-
tide Archive, PRJEB8231. [http://www.ebi.ac.uk/ena/data/
view/PRJEB8231].
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Additional files
Additional file 1: Figure S1. Bland-Altman log-ratio(M) - log average
(A) plots comparing gene expression in BLM-1 to BLM-2, which were
mixed with a designed ratio of 1:1 brain RNA, 2:1 muscle RNA and 1:2
liver RNA. Points representing gene expression values for genes expressed
at 5-fold greater levels in a specific tissue are colored based on the tissue
in which they are selectively expressed. Non-tissue selective RNA are omitted
for clarity. Library size normalization scales all libraries to a common total
number of counts, while upper quartile normalization scales to the
75th percentile of the counts for each library. None of these normalizations
accurately reflects the designed ratio of transcripts between samples.
(PNG 473 kb)
Additional file 2: Figure S2. The effect of using FPKM units. Estimates
of enrichment fraction (light points are calculated using count values,
dark points using FPKM values) result in a relatively poor solution to the
mixture proportion. Both data types are taken from the same RSEM
output. (DOC 29 kb)
Additional file 3: Figure S3. Mixture proportions returned by a simple
model (Eq. 1, blue squares), by an enrichment-corrected model
(ρ-corrected mixture equations, green triangles) and by the DeconRNASeq
package [36] (red circles) on SEQC data. Lab # - LT and - ILM indicate the
manufacturer of the sequencer used at each participating lab (Life
Technologies and Illumina, respectively).DeconRNASeq implements the
same general idea, but lacks enrichment fraction correction. In the SEQC
data, there is a relatively small enriched fraction difference between
samples, but significant improvements are nevertheless achieved by
correcting for the enriched fraction. The mean distance from true value
across all SEQC labs is 0.052 (Simple model), 0.033(enrichment-corrected),
and 0.048 (DeconRNASeq). Error bars represent the SD of four independent
libraries from the same RNA source. (PNG 78 kb)
Additional file 4: Table S1. Enrichment fraction (ρ) calculations as a
function of spike amount. Spike mass is accounted for in the enrichment
calculation. The spike-ins varied by amount (“u” or “d” samples) and content
(pools ‘a’ or ‘b’) in both tissue mixtures (1 and. 2). Calculated enrichment
fractions vary by +/- 6 % across these 10 BLM mixtures, showing that the
calculation is robust to spike-in mass and content. Enrichment calculations
for the ERCC pools must account for the 3-plex nature of the mixes. The
shown ratios are for the subset of spike-ins which are present at a 1:1 ratio
in each sample. (PNG 119 kb)
Additional file 5: Note S1. RNA-seq is capable of making transcript
isoform-specific measurements. However, long reads of high depth are
required to adequately differentiate between isoforms. Investigations of
isoform-level measurements from the BLM dataset, which utilized
75 × 35bp paired-end reads on the 5500 and 100 × 100 bp paired-
end reads on the HiSeq, showed that while the model is
extensible towards such measurements, the reduced mean read
counts make transcript isoform-level expression measurements less
precise due to shorter read length and lower sequencing depth.
92 % of genes were modeled to within 1 log2 unit of the measured
value, while only 85 % of transcripts were [38]. (DOC 28 kb)
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FPKM: Fragments per Kilobase per million mapped reads; mRNA: messenger
RNA.
Competing interests
The authors declare that they have no competing interests.
Certain equipment and instruments or materials are identified in the paper
to adequately specify the experimental details. Such identification does not imply
recommendation by the National Institute of Standards and Technology, nor
does it imply the materials are necessarily the best available for the purpose.
Authors’ contributions
All authors conducted analysis of data. The manuscript was written by JP
and edited by all authors. PP, SM, JM, MS, and MM designed BLM
experiments. Sample preparation and sequencing by JM. All authors read
and approved the final manuscript
Acknowledgements
The authors would like to thank Dr. Steve Lund for helpful feedback around
this work, and the NCI sequencing core team for sequencing.
Author details
1Material Measurement Laboratory, National Institute of Standards and
Technology, 100 Bureau Drive, Gaithersburg, MD 20899, USA. 2Leidos
Biomedical Research Inc., P.O. Box B Bldg 428, Frederick, MD 21702, USA.
3Department of Bioengineering, Stanford University, 443 Via Ortega, Stanford,
CA 94305, USA.
Received: 20 April 2015 Accepted: 9 September 2015
References
1. Van Dijk EL, Jaszczyszyn Y, Thermes C. Library preparation methods for next-
generation sequencing: tone down the bias. Exp Cell Res. 2014;322:12–20.
2. Hansen KD, Brenner SE, Dudoit S. Biases in Illumina transcriptome
sequencing caused by random hexamer priming. Nucleic Acids Res.
2010;38, e131.
3. Fu GK, Xu W, Wilhelmy J, Mindrinos MN, Davis RW, Xiao W, et al. Molecular
indexing enables quantitative targeted RNA sequencing and reveals poor
efficiencies in standard library preparations. Proc Natl Acad Sci U S A.
2014;111:1891–6.
4. Lahens NF, Kavakli IH, Zhang R, Hayer K, Black MB, Dueck H, et al. IVT-seq
reveals extreme bias in RNA sequencing. Genome Biol. 2014;15:R86.
5. Hart T, Komori HK, LaMere S, Podshivalova K, Salomon DR. Finding the
active genes in deep RNA-seq gene expression studies. BMC Genomics.
2013;14:778.
6. Wagner GP, Kin K, Lynch VJ. Measurement of mRNA abundance using
RNA-seq data: RPKM measure is inconsistent among samples. Theory
Biosci. 2012;131:281–5.
7. Raz T, Kapranov P, Lipson D, Letovsky S, Milos PM, Thompson JF. Protocol
dependence of sequencing-based gene expression measurements.
PLoS ONE. 2011;6:e19287.
8. Jue NK, Murphy MB, Kasowitz SD, Qureshi SM, Obergfell CJ, Elsisi S, et al.
Determination of dosage compensation of the mammalian X chromosome
by RNA-seq is dependent on analytical approach. BMC Genomics.
2013;14:150.
9. Jiang L, Schlesinger F, Davis CA, Zhang Y, Li R, Salit M, et al. Synthetic
spike-in standards for RNA-seq experiments. Genome Res. 2011;21:1543–51.
10. External RNA Controls Consortium. Proposed methods for testing and
selecting the ERCC external RNA controls. BMC Genomics. 2005;6:150.
11. Baker SC, Bauer SR, Beyer RP, Brenton JD, Bromley B, Burrill J, et al. The
external RNA controls consortium: a progress report. Nat Methods.
2005;2:731–4.
12. Pine PS, Rosenzweig BA, Thompson KL. An adaptable method using human
mixed tissue ratiometric controls for benchmarking performance on gene
expression microarrays in clinical laboratories. BMC Biotechnol. 2011;11:38.
13. Thompson KL, Rosenzweig BA, Pine PS, Retief J, Turpaz Y, Afshari CA, et al.
Use of a mixed tissue RNA design for performance assessments on multiple
microarray formats. Nucleic Acids Res. 2005;33, e187.
14. Duewer DL, Jones WD, Reid LH, Salit M. Learning from microarray
interlaboratory studies: measures of precision for gene expression.
BMC Genomics. 2009;10:153.
15. Li Y, Xie X. A mixture model for expression deconvolution from RNA-seq in
heterogeneous tissues. BMC Bioinformatics. 2013;14 Suppl 5:S11.
16. Shen-Orr SS, Tibshirani R, Khatri P, Bodian DL, Staedtler F, Perry NM, et al.
Cell type-specific gene expression differences in complex tissues. Nat
Methods. 2010;7:287–9.
17. Gaujoux R, Seoighe C. Semi-supervised nonnegative matrix factorization for
gene expression deconvolution: a case study. Infect Genet Evol.
2012;12:913–21.
18. Quon G, Morris Q. ISOLATE: a computational strategy for identifying the
primary origin of cancers using high-throughput sequencing. Bioinformatics.
2009;25:2882–9.
19. Gong T, Szustakowski JD. DeconRNASeq: a statistical framework for
deconvolution of heterogeneous tissue samples based on mRNA-Seq data.
Bioinformatics. 2013;29:1083–5.
20. Gong T, Hartmann N, Kohane IS, Brinkmann V, Staedtler F, Letzkus M, et al.
Optimal deconvolution of transcriptional profiling data using quadratic
Parsons et al. BMC Genomics  (2015) 16:708 Page 12 of 13
programming with application to complex clinical blood samples.
PLoS ONE. 2011;6, e27156.
21. Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia
W, et al. Inferring tumour purity and stromal and immune cell admixture
from expression data. Nat Commun. 2013;4:2612.
22. Yadav VK, De S: An assessment of computational methods for estimating
purity and clonality using genomic data derived from heterogeneous tumor
tissue samples. Brief Bioinformatics 2014.
23. Kuhn A, Thu D, Waldvogel HJ, Faull RLM, Luthi-Carter R. Population-specific
expression analysis (PSEA) reveals molecular changes in diseased brain.
Nat Methods. 2011;8:945–7.
24. Quon G, Haider S, Deshwar AG, Cui A, Boutros PC, Morris Q. Computational
purification of individual tumor gene expression profiles leads to significant
improvements in prognostic prediction. Genome Med. 2013;5:29.
25. Shen-Orr SS, Gaujoux R. Computational deconvolution: extracting cell
type-specific information from heterogeneous samples. Curr Opin Immunol.
2013;25:571–8.
26. Bock C, Lengauer T. Managing drug resistance in cancer: lessons from HIV
therapy. Nat Rev Cancer. 2012;12:494–501.
27. Yuan Y, Failmezger H, Rueda OM, Ali HR, Gräf S, Chin S-F, et al. Quantitative
image analysis of cellular heterogeneity in breast tumors complements
genomic profiling. Sci Transl Med. 2012;4:157ra143.
28. Zhao Y, Simon R. Gene expression deconvolution in clinical samples.
Genome Med. 2010;2:93.
29. Durham AL, Wiegman C, Adcock IM. Epigenetics of asthma. Biochim
Biophys Acta. 1810;2011:1103–9.
30. Liu W, Hou Y, Chen H, Wei H, Lin W, Li J, et al. Sample preparation method
for isolation of single-cell types from mouse liver for proteomic studies.
Proteomics. 2011;11:3556–64.
31. Lovén J, Orlando DA, Sigova AA, Lin CY, Rahl PB, Burge CB, et al. Revisiting
global gene expression analysis. Cell. 2012;151:476–82.
32. Aanes H, Winata C, Moen LF, Østrup O, Mathavan S, Collas P, et al.
Normalization of RNA-sequencing data from samples with varying mRNA
levels. PLoS ONE. 2014;9:e89158.
33. Robinson MD, Oshlack A. A scaling normalization method for differential
expression analysis of RNA-seq data. Genome Biol. 2010;11:R25.
34. SEQC/MAQC-III Consortium. SEQC/MAQC-III Consortium: A comprehensive
assessment of RNA-seq accuracy, reproducibility and information content
by the Sequencing Quality Control Consortium. Nat Biotechnol.
2014;32:903–14.
35. MAQC Consortium. The MicroArray Quality Control (MAQC) project shows
inter- and intraplatform reproducibility of gene expression measurements.
Nat Biotechnol. 2006;24:1151–61.
36. Munro SA, Lund SP, Pine PS, Binder H, ClevertDA, Conesa A, Salit M.
Assessing Technical Performance in Differential Gene Expression
Experiments with External Spike-in RNA Control Ratio Mixtures. Nature
Communications. 2014;65. doi:10.1038/ncomms6125.
37. Shippy R, Fulmer-Smentek S, Jensen RV, Jones WD, Wolber PK, Johnson CD,
et al. Using RNA sample titrations to assess microarray platform performance
and normalization techniques. Nat Biotechnol. 2006;24:1123–31.
38. Amaral AJ, Brito FF, Chobanyan T, Yoshikawa S, Yokokura T, Van Vactor D,
et al. Quality assessment and control of tissue specific RNA-seq libraries of
Drosophila transgenic RNAi models. Front Genet. 2014;5:43.
39. Assessing Human Stem Cell Safety [Stem Cell Information]. [http://
stemcells.nih.gov/info/scireport/pages/chapter10.aspx]
40. Brennecke P, Anders S, Kim JK, Kołodziejczyk AA, Zhang X, Proserpio V, et al.
Accounting for technical noise in single-cell RNA-seq experiments. Nat
Methods. 2013;10:1093–5.
41. Qing T, Yu Y, Du T, Shi L. mRNA enrichment protocols determine the
quantification characteristics of external RNA spike-in controls in RNA-Seq
studies. Sci China Life Sci. 2013;56:134–42.
42. Thierry-Mieg D, Thierry-Mieg J. AceView: a comprehensive cDNA-supported
gene and transcripts annotation. Genome Biol. 2006;7 Suppl 1:S12.1–14.
43. Pruitt KD, Brown GR, Hiatt SM, Thibaud-Nissen F, Astashyn A, Ermolaeva O,
et al. RefSeq: an update on mammalian reference sequences. Nucleic Acids
Res. 2014;42(Database issue):D756–63.
44. Rosenbloom KR, Sloan CA, Malladi VS, Dreszer TR, Learned K, Kirkup VM,
et al. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic
Acids Res. 2013;41(Database issue):D56–63.
45. Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F,
et al. GENCODE: the reference human genome annotation for The ENCODE
Project. Genome Res. 2012;22:1760–74.
46. Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L.
Differential analysis of gene regulation at transcript resolution with RNA-seq.
Nat Biotechnol. 2013;31:46–53.
47. Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data
with or without a reference genome. BMC Bioinformatics. 2011;12:323.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Parsons et al. BMC Genomics  (2015) 16:708 Page 13 of 13
